Detalles de la búsqueda
1.
There is More to Length of Survival than Survival: Endpoints in Oncology Trials.
Clin Cancer Res;
2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38767553
2.
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma.
Neurooncol Adv;
6(1): vdae014, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38420615
3.
Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perils.
Neuro Oncol;
26(5): 796-810, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254183
4.
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation.
Eur Urol Oncol;
7(1): 83-90, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37442672
5.
Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy.
J Stroke Cerebrovasc Dis;
32(8): 107227, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37437522
6.
Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases.
J Clin Invest;
133(10)2023 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37183819
7.
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial.
Int J Radiat Oncol Biol Phys;
117(2): 370-377, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37137444
8.
Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial.
Eur Urol;
84(2): 156-163, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37179241
9.
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
Blood Adv;
7(16): 4528-4538, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37026796
10.
Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial.
J Clin Oncol;
41(17): 3217-3224, 2023 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104723
11.
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial.
J Clin Oncol;
41(17): 3203-3216, 2023 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104748
12.
Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression.
Clin Lung Cancer;
24(3): e117-e121, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36806414
13.
A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.
Eur J Haematol;
110(5): 564-570, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36726221
14.
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.
Blood Adv;
7(6): 963-970, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973200
15.
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.
Clin Cancer Res;
28(23): 5040-5048, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36194164
16.
The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy - Authors' reply.
Lancet;
400(10356): 885-886, 2022 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36116477
17.
ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels.
Ann Surg Oncol;
29(Suppl 3): 616-617, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35930113
18.
Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview.
Curr Pediatr Rep;
10(3): 57-92, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36034212
19.
Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study.
JAMA Oncol;
8(9): 1278-1286, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35862034
20.
Evaluation of Provider Preferences in First-Line Metastatic Renal Cell Carcinoma: Comparison Between Dual Immunotherapy vs. Immunotherapy/Tyrosine Kinase Inhibitors.
Clin Genitourin Cancer;
20(6): 510-514, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35869002